Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition
07 janv. 2016 07h00 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today provided additional detail regarding its...
Sucampo Reports First Quarter 2015 Financial Results and Corporate Update
06 mai 2015 06h30 HE
|
Sucampo Pharmaceuticals Inc
Strong Financial Performance Driven by Continued Revenue and Sales Growth of AMITIZA
Strong Growth in Net Income and EPS
Company Confirms 2015 Earnings Guidance
Company to Host Conference Call...
Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA
09 oct. 2014 16h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd. (RTU), Takeda...
Sucampo Announces Departure of Chief Financial Officer
06 oct. 2014 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Cary J. Claiborne, Chief Financial...
Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone
21 août 2014 16h30 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that its subsidiary, Sucampo AG, has signed...
Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update
05 août 2014 06h15 HE
|
Sucampo Pharmaceuticals Inc
Positive Net Income Driven by Strong Revenue Growth in Product Royalty and Product Sales
CEO Peter Greenleaf to Discuss Results of Sucampo's Strategic Review
Company Raises Full Year 2014...
Sucampo Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results and Corporate Update Teleconference and Webcast on August 5
22 juil. 2014 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., July 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter 2014...
Sucampo Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote
12 juin 2014 14h41 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today issued the following statement regarding the...
Sucampo Announces Positive Top-Line Results in Phase 1a Trials of Cobiprostone and SPI-3608
07 août 2013 20h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) (Sucampo) today announced the positive top-line results of two recently completed clinical trials, a Phase...